{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T01:15:54Z","timestamp":1770081354045,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15522-w","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:04:57Z","timestamp":1767135897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Silencing TMEM105 suppresses gastric cancer cell growth and migration via proliferation-associated pathways"],"prefix":"10.1186","volume":"26","author":[{"given":"Behnoosh","family":"Nikonezhad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mobina","family":"Shahriarizade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Mahdevar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"15522_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A, Cancer statistics. 2024. CA: a cancer journal for clinicians. 2024;74(1). https:\/\/doi.org\/10.3322\/caac.21820.","DOI":"10.3322\/caac.21820"},{"issue":"3","key":"15522_CR2","doi-asserted-by":"publisher","first-page":"e70048","DOI":"10.1111\/wvn.70048","volume":"22","author":"Y Chen","year":"2025","unstructured":"Chen Y, Li L, Chen X, Yan Q, Hu X. The efficacy of decision aids on enhancing early cancer screening: A Meta-Analysis of randomized controlled trials. Worldviews Evidence\u2010Based Nurs. 2025;22(3):e70048.","journal-title":"Worldviews Evidence\u2010Based Nurs"},{"issue":"9","key":"15522_CR3","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3390\/cancers16091708","volume":"16","author":"C Burz","year":"2024","unstructured":"Burz C, Pop V, Silaghi C, Lupan I, Samasca G. Prognosis and treatment of gastric cancer: a 2024 update. Cancers. 2024;16(9):1708.","journal-title":"Cancers"},{"issue":"10494","key":"15522_CR4","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(25)00052-2","volume":"405","author":"R Sundar","year":"2025","unstructured":"Sundar R, Nakayama I, Markar SR, Shitara K, van Laarhoven HW, Janjigian YY, et al. Gastric cancer. Lancet. 2025;405(10494):2087\u2013102.","journal-title":"Lancet"},{"key":"15522_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286:18\u201324.","journal-title":"Cancer Genet"},{"issue":"1","key":"15522_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s10020-025-01075-y","volume":"31","author":"D Luo","year":"2025","unstructured":"Luo D, Liu Y, Lu Z, Huang L. Targeted therapy and immunotherapy for gastric cancer: rational strategies, novel advancements, challenges, and future perspectives. Mol Med. 2025;31(1):52.","journal-title":"Mol Med"},{"issue":"8","key":"15522_CR7","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1007\/s12035-023-03911-w","volume":"61","author":"X Wu","year":"2024","unstructured":"Wu X, Fu M, Ge C, Zhou H, Huang H, Zhong M, et al. m6A-Mediated upregulation of LncRNA CHASERR promotes the progression of glioma by modulating the miR-6893-3p\/TRIM14 axis. Mol Neurobiol. 2024;61(8):5418\u201340.","journal-title":"Mol Neurobiol"},{"key":"15522_CR8","doi-asserted-by":"publisher","first-page":"119950","DOI":"10.1016\/j.lfs.2021.119950","volume":"285","author":"M Mahdevar","year":"2021","unstructured":"Mahdevar M, Vatandoost J, Forootan FS, Kiani-Esfahani A, Esmaeili M, Peymani M, et al. Steroid receptor RNA activator gene footprint in the progression and drug resistance of colorectal cancer through oxidative phosphorylation pathway. Life Sci. 2021;285:119950.","journal-title":"Life Sci"},{"issue":"9","key":"15522_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s12032-024-02455-w","volume":"41","author":"H Elimam","year":"2024","unstructured":"Elimam H, Abdel Mageed SS, Hatawsh A, Moussa R, Radwan AF, Elfar N, et al. Unraveling the influence of LncRNA in gastric cancer pathogenesis: a comprehensive review focus on signaling pathways interplay. Med Oncol. 2024;41(9):218.","journal-title":"Med Oncol"},{"issue":"6","key":"15522_CR10","doi-asserted-by":"publisher","first-page":"e13423","DOI":"10.1111\/cpr.13423","volume":"56","author":"D Li","year":"2023","unstructured":"Li D, Xia L, Huang P, Wang Z, Guo Q, Huang C, et al. Heterogeneity and plasticity of epithelial\u2013mesenchymal transition (EMT) in cancer metastasis: focusing on partial EMT and regulatory mechanisms. Cell Prolif. 2023;56(6):e13423.","journal-title":"Cell Prolif"},{"issue":"1","key":"15522_CR11","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13046-024-03103-x","volume":"43","author":"S Qin","year":"2024","unstructured":"Qin S, Liu Y, Zhang X, Huang P, Xia L, Leng W, et al. LncRNA FGD5-AS1 is required for gastric cancer proliferation by inhibiting cell senescence and ROS production via stabilizing YBX1. J Experimental Clin Cancer Res. 2024;43(1):188.","journal-title":"J Experimental Clin Cancer Res"},{"key":"15522_CR12","doi-asserted-by":"publisher","first-page":"1552773","DOI":"10.3389\/fonc.2025.1552773","volume":"15","author":"W Liu","year":"2025","unstructured":"Liu W, Wang W. LncRNA in gastric cancer drug resistance: Deciphering the therapeutic strategies. Front Oncol. 2025;15:1552773.","journal-title":"Front Oncol"},{"key":"15522_CR13","doi-asserted-by":"publisher","unstructured":"Li D, Zhou Z, Hui Y, Yu H, Ren T, Zhai L et al. EHBMT, a method for visualizing tumor evolution, identifies a surge in gastric cancer with hybrid epithelial\u2013mesenchymal phenotypes due to an inflammatory microenvironment. Exp Mol Med. 2025:1\u201318. https:\/\/doi.org\/10.1038\/s12276-025-01570-6.","DOI":"10.1038\/s12276-025-01570-6"},{"issue":"1","key":"15522_CR14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41419-025-08029-6","volume":"16","author":"D Li","year":"2025","unstructured":"Li D, Zhou Z, Li X, Guo Q, Yuan L, Zhang X, et al. Hypermethylation-mediated HNF4A Silencing by Helicobacter pylori infection drives gastric cancer by disrupting epithelial cell Polarity and activating EMT signaling. Cell Death Dis. 2025;16(1):688.","journal-title":"Cell Death Dis"},{"issue":"5","key":"15522_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41419-024-06744-0","volume":"15","author":"S Qin","year":"2024","unstructured":"Qin S, Guo Q, Liu Y, Zhang X, Huang P, Yu H, et al. A novel TGFbeta\/TGILR axis mediates crosstalk between cancer-associated fibroblasts and tumor cells to drive gastric cancer progression. Cell Death Dis. 2024;15(5):368.","journal-title":"Cell Death Dis"},{"issue":"5","key":"15522_CR16","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.7150\/ijbs.104598","volume":"21","author":"Y Yin","year":"2025","unstructured":"Yin Y, Sun Y, Yao H, Yu F, Jia Q, Hu C, et al. TMEM105 modulates Disulfidptosis and tumor growth in pancreatic cancer via the \u03b2-catenin-c-MYC-GLUT1 axis. Int J Biol Sci. 2025;21(5):1932.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"15522_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41419-023-05628-z","volume":"14","author":"J Han","year":"2023","unstructured":"Han J, Chen X, Wang J, Liu B. Glycolysis-related LncRNA TMEM105 upregulates LDHA to facilitate breast cancer liver metastasis via sponging miR-1208. Cell Death Dis. 2023;14(2):80.","journal-title":"Cell Death Dis"},{"issue":"10","key":"15522_CR18","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3390\/jpm12101696","volume":"12","author":"A Paszkowska","year":"2022","unstructured":"Paszkowska A, Kolenda T, Guglas K, Koz\u0142owska-Mas\u0142o\u0144 J, Podralska M, Teresiak A, et al. C10orf55, CASC2, and SFTA1P LncRNAs are potential biomarkers to assess radiation therapy response in head and neck cancers. J Personalized Med. 2022;12(10):1696.","journal-title":"J Personalized Med"},{"key":"15522_CR19","doi-asserted-by":"publisher","first-page":"778557","DOI":"10.3389\/fonc.2021.778557","volume":"11","author":"X Chen","year":"2021","unstructured":"Chen X, Zhu Z, Li X, Yao X, Luo L. The ferroptosis-related noncoding RNA signature as a novel prognostic biomarker in the tumor microenvironment, immunotherapy, and drug screening of gastric adenocarcinoma. Front Oncol. 2021;11:778557.","journal-title":"Front Oncol"},{"issue":"8","key":"15522_CR20","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71\u2013e.","journal-title":"Nucleic Acids Res"},{"key":"15522_CR21","doi-asserted-by":"publisher","unstructured":"Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010). edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26(1):139\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616.","DOI":"10.1093\/bioinformatics\/btp616"},{"key":"15522_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fgene.2016.00164","volume":"7","author":"E Maza","year":"2016","unstructured":"Maza E. Papyro comparison of TMM (edgeR), RLE (DESeq2), and MRN normalization methods for a simple two-conditions-without-replicates RNA-Seq experimental design. Front Genet. 2016;7:164.","journal-title":"Front Genet"},{"issue":"2","key":"15522_CR23","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29.","journal-title":"Genome Biol"},{"issue":"3","key":"15522_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier L, Cope L, Bolstad BM, Irizarry RA. affy\u2014analysis of affymetrix genechip data at the probe level. Bioinformatics. 2004;20(3):307\u201315.","journal-title":"Bioinformatics"},{"issue":"1","key":"15522_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12935-022-02751-3","volume":"22","author":"M Sajadi","year":"2022","unstructured":"Sajadi M, Fazilti M, Nazem H, Mahdevar M, Ghaedi K. The expression changes of transcription factors including ANKZF1, LEF1, CASZ1, and ATOH1 as a predictor of survival rate in colorectal cancer: a large-scale analysis. Cancer Cell Int. 2022;22(1):339.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"15522_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9(1):559.","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"15522_CR27","doi-asserted-by":"publisher","first-page":"D1034","DOI":"10.1093\/nar\/gky905","volume":"47","author":"Z Bao","year":"2019","unstructured":"Bao Z, Yang Z, Huang Z, Zhou Y, Cui Q, Dong D. LncRNADisease 2.0: an updated database of long non-coding RNA-associated diseases. Nucleic Acids Res. 2019;47(D1):D1034\u20137.","journal-title":"Nucleic Acids Res"},{"key":"15522_CR28","doi-asserted-by":"publisher","first-page":"612393","DOI":"10.3389\/fmed.2020.612393","volume":"7","author":"Y Qian","year":"2020","unstructured":"Qian Y, Shi L, Luo Z. Long non-coding RNAs in cancer: implications for diagnosis, prognosis, and therapy. Front Med. 2020;7:612393.","journal-title":"Front Med"},{"key":"15522_CR29","doi-asserted-by":"publisher","first-page":"1602252","DOI":"10.3389\/fimmu.2025.1602252","volume":"16","author":"PS Ramalingam","year":"2025","unstructured":"Ramalingam PS, Zhang L, Hussain MS, Khan G, Mawkili W, Hanbashi A, et al. Non-coding RNAs as key regulators in hepatitis B virus-related hepatocellular carcinoma. Front Immunol. 2025;16:1602252.","journal-title":"Front Immunol"},{"issue":"1","key":"15522_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/s12967-024-05554-4","volume":"22","author":"K Grillone","year":"2024","unstructured":"Grillone K, Carid\u00e0 G, Luciano F, Cordua A, Di Martino MT, Tagliaferri P, et al. A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer. J Translational Med. 2024;22(1):731.","journal-title":"J Translational Med"},{"key":"15522_CR31","doi-asserted-by":"publisher","unstructured":"Ho Y-L, Ho Y-J, Ko F-Y, Ho S-Y, editors. Evolutionary learning-derived lncRNA signature with biomarker discovery for predicting stage of colon adenocarcinoma. 2024 46th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC); 2024: IEEE. https:\/\/doi.org\/10.1109\/EMBC53108.2024.10781761.","DOI":"10.1109\/EMBC53108.2024.10781761"},{"key":"15522_CR32","doi-asserted-by":"publisher","unstructured":"Huang Y, Lv Y, Yang B, Zhang S, Zhang C, Hu W et al. Enhancing m6A modification of LncRNA through METTL3 and RBM15 to promote malignant progression in bladder cancer. Heliyon. 2024;10(7). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28165.","DOI":"10.1016\/j.heliyon.2024.e28165"},{"issue":"1","key":"15522_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13062-024-00518-6","volume":"19","author":"Z Liu","year":"2024","unstructured":"Liu Z, Sun L, Zhu W, Zhu J, Wu C, Peng X, et al. Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer. Biol Direct. 2024;19(1):65.","journal-title":"Biol Direct"},{"issue":"11","key":"15522_CR34","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.62347\/MJOA5699","volume":"16","author":"H Zhang","year":"2024","unstructured":"Zhang H, Jiang Y, Luo J, Tan Q, Xu M, He B. Predictive and prognostic value of combined detection of sTim-3, PG and PD-L1 in immune checkpoint inhibitor therapy for advanced gastric cancer. Am J Translational Res. 2024;16(11):6955.","journal-title":"Am J Translational Res"},{"issue":"3","key":"15522_CR35","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/toxres\/tfad024","volume":"12","author":"W Peng","year":"2023","unstructured":"Peng W, Chen L, Liu J. Celastrol inhibits gastric cancer cell proliferation, migration, and invasion via the FOXA1\/CLDN4 axis. Toxicol Res. 2023;12(3):392\u20139.","journal-title":"Toxicol Res"},{"key":"15522_CR36","doi-asserted-by":"publisher","first-page":"901559","DOI":"10.3389\/fphar.2022.901559","volume":"13","author":"G Tong","year":"2022","unstructured":"Tong G, Peng T, Chen Y, Sha L, Dai H, Xiang Y, et al. Effects of GLP-1 receptor agonists on biological behavior of colorectal cancer cells by regulating PI3K\/AKT\/mTOR signaling pathway. Front Pharmacol. 2022;13:901559.","journal-title":"Front Pharmacol"},{"key":"15522_CR37","doi-asserted-by":"publisher","unstructured":"Sun M, Wang M, Gao H, Li L, Wu M, Li Q et al. The interplay between post-transcriptional RNA regulation and Wnt\/\u03b2-Catenin signaling in cancer: A review. Int J Biol Macromol. 2025:147657. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147657.","DOI":"10.1016\/j.ijbiomac.2025.147657"},{"issue":"1","key":"15522_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","volume":"7","author":"Z-N Lei","year":"2022","unstructured":"Lei Z-N, Teng Q-X, Tian Q, Chen W, Xie Y, Wu K, et al. Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduct Target Therapy. 2022;7(1):358.","journal-title":"Signal Transduct Target Therapy"},{"issue":"2","key":"15522_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","volume":"127","author":"X Sun","year":"2018","unstructured":"Sun X, Kaufman PD. Ki-67: more than a proliferation marker. Chromosoma. 2018;127(2):175\u201386.","journal-title":"Chromosoma"},{"issue":"2","key":"15522_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/15384101.2019.1706903","volume":"19","author":"G Tchakarska","year":"2020","unstructured":"Tchakarska G, Sola B. The double dealing of Cyclin D1. Cell Cycle. 2020;19(2):163\u201378.","journal-title":"Cell Cycle"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15522-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15522-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T14:06:29Z","timestamp":1770041189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15522-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15522"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15522-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The review board at Emam Khomeini Hospital validated all bioethical issues in accordance with Iran\u2019s Ministry standards. Informed consent was obtained from participants. Ethical approval was granted by the Internal Ethics Committee of the Genius Gene Research Center (IR-GG-1402-018). This study involved only laboratory analysis of anonymized human samples and did not include any direct human intervention. This study was conducted in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors support the submission of the present manuscript to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}